Visalytics
Visalytics
approved EB-2 (NIW)

Adjunct Clinical Assistant Professor

Pharmacy · South Korea · 2022-06-07

Processing Time
10 days
Decision Date
2022-06-07
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in health and social pharmacy, specifically focusing on pharmaceutical policy and outcome research. Her work aims to advance effective and cost-effective treatment options for obesity, self-administered acupressure therapies, and symptom control for asthmatic patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses obesity and asthma management, which are significant health concerns with direct benefits to U.S. public health and cost-effective care.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her Ph.D., 52 publications, and high citation count ranking her in the top 1% of her field.

3 Waiver of Job Offer and Labor Certification Met

On balance, her unique expertise in cost-effective CAM therapies and obesity research makes her contributions sufficiently beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in health and social pharmacy and a prolific publication record of 52 journal articles. These works garnered 635 citations from peers in 56 countries, placing her in the top 1% of cited authors in her field. Additionally, she completed 12 peer reviews and secured funding from major international health institutes, satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Grants
Reference Letters Independent
Original Contributions

Similar Cases

Assistant Professor

Biotechnology · Jordan

WeGreened EB-2 (NIW) approved
North Carolina 4 days 2023-08-01
The petitioner proposes to continue his research in identifying novel metabolic targets to treat obesity-associated pathologies and restoring protective immunity. His work focuses on expanding the knowledge base in medical and associated sciences to enhance national health through an advanced understanding of obesity and viable treatments.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.
View Case

Research Assistant

Healthcare · Ghana

WeGreened EB-2 (NIW) rfe approved
Connecticut 373 days 2025-04-05
The petitioner proposes to advance the fight against obesity-related diseases by developing digital behavioral interventions and tailored weight loss programs. This research leverages experimental study designs to build effective tools for weight loss, aiming to reduce risks associated with cardiovascular disease and type 2 diabetes. The work focuses on utilizing digital health messaging and social media-based interventions to improve public health outcomes.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from South Korea

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-06-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 10 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in South Korea All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist